As a companion to our recent guidance on patent eligibility in the USA, Ian Robinson explores the revised 2019 guidelines for applications with ‘functional limitations’ in their claims.Learn more
David Walsh, Rachel Mercer and James Myatt discuss the recent decision regarding Warner-Lambert Company LLC v Generics Ltd t/a Mylan and Actavis Group.Learn more
On 25 October 2018 the Court of Justice of the European Union (CJEU) handed down its judgment on the case C-527/17 relating to supplementary protection certificates (SPCs) for drug-device combination products.Learn more
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.